ANGIODYNAMICS INC — Director's Dealing 2011

Sep 9, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2011-09-07

Reporting Person: DEVIVO JOSEPH (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-07	Common Stock	A	25000	—	Acquired	25000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-07	Non-Qualified Stock Option (right to buy)	$13.94	A	400000	Acquired	2018-09-07	Common Stock (400000)	Direct

Footnotes

F1: The acquisition of 25,000 shares of common stock represents 25,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 9/7/2012.

F2: Options for 25% of the shares are each exercisable on 9/7/2012, 9/7/2013, 9/7/2014 and 9/7/2015, respectively.